Subtype and genotypic resistance analysis of HIV-1 infected patients in Austria

Wiener Klinische Wochenschrift

Volumn 119, Issue 5-6, 2007, Pages 181-185

  Falkensammer, Barbara ^a   Doerler, Martin ^a   Kessler, Harald H ^b   Puchhammer Stoeckl, Elisabeth ^c   Parson, Walter ^a   Duftner, Christina ^d   Dierich, Manfred P ^a   Stoiber, Heribert ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b MEDICAL UNIVERSITY OF GRAZ   (Austria)

^c UNIVERSITY OF VIENNA   (Austria)

^d INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Austria; Circulating recombinant forms; Genotypic resistance; HIV 1; Subtypes

Indexed keywords

ANTIRETROVIRUS AGENT; PROTEINASE; RNA DIRECTED DNA POLYMERASE;

ADULT; ALGORITHM; ARTICLE; AUSTRIA; BLOOD SAMPLING; CONTROLLED STUDY; GENE AMPLIFICATION; GENE SEQUENCE; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INFECTION RESISTANCE; MUTAGENESIS; NONHUMAN; PHYLOGENY; PREVALENCE; VIRAL GENETICS; VIRUS STRAIN;

ADULT; ANTIVIRAL AGENTS; DRUG RESISTANCE, VIRAL; EMIGRATION AND IMMIGRATION; FEMALE; GENOTYPE; HIV INFECTIONS; HIV PROTEASE; HIV-1; HIV-1 REVERSE TRANSCRIPTASE; HUMANS; MALE; PHYLOGENY; POLYMERASE CHAIN REACTION; RECOMBINATION, GENETIC; RETROSPECTIVE STUDIES; VIRAL LOAD;

EID: 34250870613     PISSN: 00435325     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00508-006-0745-4     Document Type: Article

References (28)

1. Carr JK, Foley BT, Leitner T, Salminen M, Korber B, McCutchan F (1998) Reference sequences representing the principal genetic diversity of HIV-1 in the pandemic. In: Human retroviruses and AIDS, part III. Los Alamos National Laboratory, Los Alamos, NM, pp 10-17
2. Takebe Y, Kusagawa S, Motomura K (2004) Molecular epidemiology of HIV: tracking AIDS pandemic. Pediatr Int 46: 236-244
3. Balint GA (2000) Can it be worse? On the sub-Saharan HIV/AIDS epidemic at the beginning of the new millennium. Wien Klin Wochenschr 112: 1059-1061
4. Puchhammer-Stockl E, Kunz C, Faatz E, Kasper P, Heinz FX (1998) Introduction of HIV-11 subtypes C, E and A into Austria. Clin Diagn Virol 9: 25-28
5. Kessler HH, Deuretzbacher D, Stelzl E, Daghofer E, Santner BI, Marth E (2001) Determination of human immunodeficiency virus type 1 subtypes by a rapid method useful for the routine diagnostic laboratory. Clin Diagn Lab Immunol 8: 1018-1020
6. German AIDS Society, Austrian AIDS Society, Drug Committee of the German Medical Board, German Union of Registered Physicians for the Treatment of HIV and AIDS Patients, German Cochrane Group, German Surgical Association, et al (2003) Antiretroviral therapy of HIV infection. German-Austrian recommendations 2002. Eur J Med Res 8: 257-274
7. Walter H, Schmidt B, Korn K, Vandamme AM, Harrer T, Uberla K (1999) Rapid, phenotypic HIV-1 drug sensitivity assay for protease and reverse transcriptase inhibitors. J Clin Virol 13: 71-80
8. Falkensammer B, El Attal R, Muellauer B, Sarcletti M, Parson W, Dierich MP et al (2002) Loss of zidovudine related mutations in the reverse transcriptase gene of HIV after switching therapy. Eur J Med Res 7: 379-386
9. Puchhammer-Stockl E, Steininger C, Geringer E, Heinz FX (2002) Comparison of virtual phenotype and HIV-SEQ program (Stanford) interpretation for predicting drug resistance of HIV strains. HIV Med 3: 200-206
10. Nicholas KB, Nicholas HB, Deerfield DW (1997) GeneDoc: analysis and visualization of genetic variation. EMBnet News 4: 14-18
11. Thompson JD, Gibson TJ, Plewniak F, Jeanmougin F, Higgins DG (1997) The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res 25: 4876-4882
12. Kumar S, Tamura K, Jakobsen IB, Nei M (2001) MEGA2: molecular evolutionary genetics analysis software. Bioinformatics 17: 1244-1245
13. Lole KS, Bollinger RC, Paranjape RS, Gadkari D, Kulkarni SS, Novak NG, et al (1999) Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination. J Virol 73: 152-160
14. Shafer RW (2002) Genotypic testing for human immunodeficiency virus type 1 drug resistance. Clin Microbiol Rev 15: 247-277
15. Tomaso H, Reisinger EC, Grasmug E, Ramschak H, Kreis GJ (1995) Wien Klin Wochenschr 107: 85-90
16. Jagodzinski LL, Wiggins DL, McManis JL, Emery S, Overbaugh J, Robb M, et al (2000) Use of calibrated viral load standards for group M subtypes of human immunodeficiency virus type 1 to assess the performance of viral RNA quantitation tests. J Clin Microbiol 38: 1247-1249
17. Antunes R, Figueiredo S, Bartolo I, Pinheiro M, Rosado L, Soares I, et al (2003) Evaluation of the clinical sensitivities of three viral load assays with plasma samples from a pediatric population predominantly infected with human immunodeficiency virus type 1 subtype G and BG recombinant forms. J Clin Microbiol 41: 3361-3367
18. Kanki PJ, Hamel DJ, Sankale JL, Hsieh C, Thior I, Barin F, et al (1999) Human immunodeficiency virus type 1 subtypes differ in disease progression. J Infect Dis 179: 68-73
19. Montano MA, Nixon CP, Ndung'u T, Bussmann H, Novitsky VA, Dickman D, et al (2000) Elevated tumor necrosis factor-alpha activation of human immunodeficiency virus type 1 subtype C in Southern Africa is associated with an NF-kappaB enhancer gain-of-function. J Infect Dis 181: 76-81
20. Blackard JT, Renjifo B, Fawzi W, Hertzmark E, Msamanga G, Mwakagile D, et al (2001) HIV-1 LTR subtype and perinatal transmission. Virology 287: 261-265
21. Renjifo B, Fawzi W, Mwakagile D, Hunter D, Msamanga G, Spiegelman D, et al (2001) Differences in perinatal transmission among human immunodeficiency virus type 1 genotypes. J Hum Virol 4: 16-25
22. Thomson MM, Najera R (2001) Travel and the introduction of human immunodeficiency virus type 1 non-B subtype genetic forms into Western countries. Clin Infect Dis 32: 1732-1737
23. Pieniazek D, Rayfield M, Hu DJ, Nkengasong J, Wiktor SZ, Downing R, et al (2000) Protease sequences from HIV-1 group M subtypes A-H reveal distinct amino acid mutation patterns associated with protease resistance in protease inhibitor-naive individuals worldwide. HIV Variant Working Group. AIDS 14: 1489-1495
24. Vergne L, Peeters M, Mpoudi-Ngole E, Bourgeois A, Liegeois F, Toure-Kane C, et al (2000) Genetic diversity of protease and reverse transcriptase sequences in non-subtype-B human immunodeficiency virus type 1 strains: evidence of many minor drug resistance mutations in treatment-naive patients. J Clin Microbiol 38: 3919-3925
25. Apetrei C, Descamps D, Collin G, Robertson DL, Pandrea I, Groza P, et al (2003) HIV type 1 diversity in northeastern Romania in 200-2001 based on phylogenic analysis of pol sequences from patient failing antiretroviral therapy. AIDS Res Hum Retroviruses 19: 1155-1161
26. Kantor R, Katzenstein DA, Efron B, Carvalho AP, Wynhoven B, Cane P, et al (2005) Impact of HIV-1 subtype and antiretroviral therapy on protease and reverse transcriptase genotype: results of a global collaboration. PLoS Med 2: p112
27. Puthanakit T, Oberdorfer A, Akarathum N, Kanjanavanit S, Wannarit P, Sirisanthana T, et al (2005) Efficacy of highly active antiretroviral therapy in HIV-infected children participating in Thailand's National Access to Antiretroviral Program. Clin Infect Dis 41: 100-110
28. Moutouh L, Corbeil J, Richman DD (1996) Recombination leads to the rapid emergence of HIV-1 dually resistant mutants under selective drug pressure. Proc Natl Acad Sci USA 11: 6106-6111